Results

Total Results: 705 records

Showing results for "drugs".

121. Appendix 3: Data Abstraction (xls file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/ced-appendix3-data-abstraction.xlsx
     June 24, 2022 - National Institute for Health and Care Excellence (NICE) Specification for Cancer Drugs Fund data collection … www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisal-guidance/cancer-drugs-fund

122. Questions and Answers About the CAHPS Cancer Care Survey (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/questions-and-answers-about-cancer-care-survey.pdf
     September 12, 2017 - Questions and Answers About the CAHPS Cancer Care Survey 1 Questions and Answers About the CAHPS® Cancer Care Survey Q: Why are there three versions of the CAHPS Cancer Care Survey, and do I need to field them all? A: The three versions of the Cancer Care Survey reflect the three most common treatment modalities…

123. Data Resources | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/data/resources/index.html?page=4
     April 29, 2024 - Opioids (1) Patient Experience (1) Payment Sources (1) Premiums (1) Prescription Drugs

124. Pediatric Health Care Quality Measures: Considerations for Pharmacotherapy (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/LomotanDougherty2013.pdf
     April 01, 2013 - Pediatric Health Care Quality Measures: Considerations for Pharmacotherapy Pediatr Drugs DOI 10.1007 … conditions where children experience 60 % of the disease burden, only 12 % of the clinical trials for drugs … Pediatr Drugs. 2009;11(1):41–4. 17. Hoppu K, Anabwani G, Garcia-Bournissen F, et al.

125. Implementation Quick Start Guide: Medication Mangement (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-family-engagement/pfeprimarycare/medmanage_quickstartfull.pdf
     December 15, 2016 - Implementation Quick Start Guide: Medication Mangement Implementation Quick Start Guide Medication Management The Guide to Improving Patient Safety in Primary Care Settings by Engaging Patients and Families Implementation Quick Start Guide: Medication Management Table of Contents What Is the Medication Man…

126. Health Literacy in Pharmacy: Introduction | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/health-literacy/professional-training/pharmacy/resources/slides/intro.html
     September 01, 2020 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

127. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
     January 01, 2009 - and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.

128. Improving Patient Safety in Community Pharmacies: A Resource List for Users of the AHRQ Community Pharmacy Survey on Patient Safety Culture (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/community-pharmacy/pharmacy-resources.pdf
     May 01, 2023 - Improving Patient Safety in Community Pharmacies: A Resource List for Users of the AHRQ Community Pharmacy Survey on Patient Safety Culture Improving Patient Safety in Community Pharmacies: A Resource List for Users of the AHRQ Community Pharmacy Survey on Patient Safety Culture I. Purpose This document provide…

129. CHIPRA 212 Appendix 2 (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-appendix-2.pdf
     January 17, 2024 - CHIPRA 212 Appendix 2 APPENDIX 2 - INHALED CORTICOSTEROIDS (ICS) ICS NDC Code Brand Name Generic Product Name Route Drug ID Device FDA-Age (Years) Chamber Chamber w/Mask Nebulizer w/Mask or Mouth Piece Daily Controller Med 54868599000 Alvesco HFA ciclesonide CFC free 160 mcg/inh inhalation aerosol…

130. Guidelines for Translating CAHPS® Surveys | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/cahps/surveys-guidance/helpful-resources/resources/cahpsGuidelines_Translation.html
     March 01, 2016 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

131. Implementation Quick Start Guide: Medication Management (Half-Page) (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-family-engagement/pfeprimarycare/medmanage_quickstartbrochure.pdf
     December 15, 2016 - Implementation Quick Start Guide: Medication Management (Half-Page) Implementation Quick Start Guide Medication Management The Guide to Improving Patient Safety in Primary Care Settings by Engaging Patients and Families Table of Contents What Is the Medication Management Strategy? ...................1 W…

132. The “Usually Antibiotics” Diagnoses: Community-Acquired Pneumonia – Slides
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/cap-slides.pptx
     September 01, 2022 - Mar 8, 2018. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics

133. About the Nursing Home Antimicrobial Stewardship Guide | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/nhguide/about/index.html
     March 01, 2023 - Antibiotic resistance occurs when bacteria adapt so that the drugs used to treat infections are less

134. Home | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/
     January 01, 2019 - Program Improving healthcare quality by providing the best available evidence on benefits and harms of drugs

135. Chapter 6. Measure Maps and Profiles (continued, 10) | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/ncepcr/care/coordination/atlas/chapter6i.html
     June 01, 2014 - J Stud Alcohol Drugs 2008;69(5):747-56. Measure #22b. … J Stud Alcohol Drugs 2008;69(5):747-56.

136. Process
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/pharmlitqi/slidedeck3/slidedeck3.pptx
     March 01, 2011 - As a 340B pharmacy they receive low-priced drugs from the Federal government because of the population

137. Appendix, Data Collection Strategy, Assessment, and Process Evaluation | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/patient-safety/settings/hospital/match/appendix/app-6a.html
     July 01, 2022 - If a patient will be provided/given any medications while under our care or prescribed any new drugs

138. Table A.4.1. Verisk condition classifications | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/practiceimprovement/delivery-initiative/ihs/taba.4.1.html
     December 01, 2017 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

139. Acute Care Asymptomatic Bacteriuria and Urinary Tract Infections
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/allergies-slides.pptx
     September 01, 2022 - Acute Care Asymptomatic Bacteriuria and Urinary Tract Infections Best Practices in the Management of Patients With Antibiotic Allergies Ambulatory Care AHRQ Safety Program for Improving Antibiotic Use AHRQ Pub. No. 17(22)-0030 September 2022 Antibiotic Allergies AHRQ Safety Program for Improving Antibiotic Us…

140. New Data Resources Provide Insights Into Patient Safety Risks | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/news/newsletters/e-newsletter/885.html
     October 01, 2023 - Literature Time to confirmatory study initiation after accelerated approval of cancer and noncancer drugs